Monday, Dec 4, 2023 · SEC filings
What the smart money revealed on Dec 4
697 insider filings came in. We hid 81 planned (10b5-1) sellers and 429 people whose filings were routine, like grants and tax withholding.
Pulse Biosciences (PLSE) Director Robert Duggan bought $1.39M
152,944 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 6 checked quarters beat the typical stock 6 months later.
Redwood Enhanced Income Co-Chairman and Co-President Ruben Kliksberg bought $844K
63,969 shares on the open market. Not a grant or an option exercise.
First Busey (BUSE) Director Stanley Bradshaw bought $456K
20,800 shares on the open market. Not a grant or an option exercise. Their past buys: 4 of 6 checked quarters beat the typical stock 6 months later.
Redwood Enhanced Income Co-Chairman and Co-President Sean Sauler bought $281K
21,323 shares on the open market. Not a grant or an option exercise.
M&T Bank (MTB) Director Kirk Walters sold $3.77M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 7,088 shares directly.
Zscaler (ZS) Director Charles Giancarlo sold $3.52M
Not marked as a planned 10b5-1 sale. Sold 50% of the shares they held directly. Still holds 17,824 shares.
Charles Schwab (SCHW) General Counsel Peter Morgan III sold $435K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 59 more real buys
Show 88 more real sales
13F season
Holdings as of Sep 30, 2023 were due Nov 14
40 funds have filed. 40 filed for the quarter before.
Biggest real insider buys, Nov 28–Dec 4
Open-market buys by officers and directors, filed in the 7 days up to Dec 4.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.